Chronic Lymphocytic Leukemia (CLL) Algorithm

home / treatment-algorithms-with-the-oncology-brothers / chronic-lymphocytic-leukemia-cll-algorithm

Nitin Jain, MD, joins Rohit Gosain, MD, and Rahul Gosain, MD, of Oncology Brothers to discuss treatment sequencing for chronic lymphocytic leukemia, covering both first-line and later-line therapies, while emphasizing the important role of Bruton's tyrosine kinase inhibitors in managing this condition.

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 1: Observation Versus Treatment for Patients with CLL

Rohit Gosain, MD;Rahul Gosain, MD;Nitin Jain, MD
April 29th 2024

Medical professionals discuss factors influencing the decision between observation and treatment, optimal diagnostic methods for chronic lymphocytic leukemia (CLL), and key markers to assess in patients with suspected CLL.

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 2: Personalized Medicine: Optimizing Outcomes for Patients with CLL

Rohit Gosain, MD;Rahul Gosain, MD;Nitin Jain, MD
April 29th 2024

Nitin Jain, MD, presents data on the efficacy of various chronic lymphocytic leukemia treatments, reviews current guidelines, discusses the increasing use of Bruton's tyrosine kinase inhibitors and the decreasing role of chemotherapy in his practice. He emphasizes the importance of considering patient factors and preferences in treatment decision-making.

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 3: Comparing BTK Inhibitors for Optimal CLL Treatment

Rohit Gosain, MD;Rahul Gosain, MD;Nitin Jain, MD
April 29th 2024

Nitin Jain, MD, discusses the increasing use of various Bruton's tyrosine kinase inhibitors as front-line treatment options for patients with chronic lymphocytic leukemia.

Rahul Gosain, MD; Nitin Jain, MD; and Rohit Gosain, MD, presenting slides

EP. 4: Advancing CLL Treatment: Latest Updates and Strategies

Rohit Gosain, MD;Rahul Gosain, MD;Nitin Jain, MD
April 29th 2024

Nitin Jain, MD, discusses a novel treatment approach for chronic lymphocytic leukemia, along with stem cell transplantation and other later-line therapies and treatment options for managing CLL.